Search Results - "Noesselt, Thomas"
-
1
Multifocal invasive ductal breast cancer with osteoclast-like giant cells: a case report
Published in Journal of medical case reports (27-02-2011)“…To the best of our knowledge, this is the first case report of a multifocal (trifocal) invasive carcinoma of the breast containing osteoclast-like giant cells…”
Get full text
Journal Article -
2
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
Published in Journal of clinical oncology (2024)“…JCO .Although dose-dense adjuvant chemotherapy administered once every 2 weeks leads to superior outcomes compared with standard regimens once every 3 weeks,…”
Get full text
Journal Article -
3
Guideline adherence and clinical outcome in vulnerable and healthy breast cancer patients: Results of a prospective cross-sectional study in Germany
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e18132 Background: In 2003 the German Cancer Society and the German Society for Breast Disease introduced a number of Quality Indicators (QIs) to…”
Get full text
Journal Article -
4
Prospective cross-sectional-study on influence of immigration background and education on breast cancer survival in a real-world setting
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer
Published in Breast care (Basel, Switzerland) (01-10-2021)“…Background: Although immigrant health is an important issue in national health policy, there is a serious shortage of data in many countries. Most studies lack…”
Get full text
Journal Article -
6
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial
Published in JAMA oncology (01-07-2022)“…Adjuvant denosumab might improve disease-free survival in hormone receptor (HR)-positive primary breast cancer (BC). The optimal neoadjuvant nab-paclitaxel…”
Get more information
Journal Article -
7
Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after Breast Cancer
Published in Die Rehabilitation (01-04-2021)“…This study explores the sociodemographic, medical and work-related factors leading to a participation in an in-house rehabilitation measure after primary…”
Get more information
Journal Article -
8
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study
Published in BMC cancer (21-06-2019)“…Treatment of postmenopausal, hormone receptor-positive metastatic breast cancer (MBC) patients varies despite clear therapy guidelines, favoring endocrine…”
Get full text
Journal Article -
9
Hormone receptor discordance between local and central pathology with RT-PCR analysis: Results from multicenter Phase III WSG-PlanB trial
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
10
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Published in Breast care (Basel, Switzerland) (01-10-2016)“…Background: Decision-making for or against neoadjuvant or adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive breast cancer does…”
Get full text
Journal Article